SCHEMBL4692483

SCHEMBL4692483

CCOC(=O)c1cc(-c2ccc(C(C)(C)C)cc2)n[nH]1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 7/20 0.72
MAPT P10636 7/20 0.70
RAB9A P51151 5/20 0.70
NPC1 O15118 4/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
ACR P10323 1/20 0.57
KMT2A Q03164 1/20 0.56
POLB P06746 1/20 0.56
HPGDS O60760 2/20 0.55
NR1H4 Q96RI1 1/20 0.54
CA12 O43570 1/20 0.52
CA9 Q16790 1/20 0.52
LMNA P02545 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
TP53 P04637 1/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
PPARG P37231 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4090739 0.88 ALPL (0.70) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL25168483 0.84 ALPL (0.76) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL1413959 0.84 ALPL (1.00) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL2824803 0.84 ALPL (0.76) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL595997 0.83 ALPL (0.75) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL2888912 0.83 MAPT (1.00) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL4712555 0.82 ALPL (0.73) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL4683636 0.82 MAPT (0.75) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL10070273 0.82 ALPL (0.72) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL5937220 0.81 ALPL (0.70) ALPLMAPTRAB9ANPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685113-B1 SUBSTITUTED PYRAZOLES AS PPAR AGONISTS SMITHKLINE BEECHAM CORP (US) 2008-07-30 EP disclosed
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists SMITHKLINE BEECHAM CORPORATION 2008-01-24 US disclosed
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists SMITHKLINE BEECHAM CORPORATION 2008-01-24 US disclosed
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists SMITHKLINE BEECHAM CORPORATION 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists PPARD, PPARA, PPARG ALPL 3658/4885MAPT 4679/4885RAB9A 3248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.